Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Asterosaponin 1, a cytostatic compound from the starfish Culcita novaeguineae, functions by inducing apoptosis in human glioblastoma U87MG cells.
Cheng G
,
Zhang X
,
Tang HF
,
Zhang Y
,
Zhang XH
,
Cao WD
,
Gao DK
,
Wang XL
,
Jin BQ
.
???displayArticle.abstract???
Malignant glioblastoma is one of the most common malignant tumors in the neurological system. Asterosaponin 1, a new cytostatic agent from the starfish Culcita novaeguineae appear to exhibit various biological activities, including antitumor effect, but the function and mechanism of this new agent on glioblastoma cells has not previously been determined. In the present study, we investigated the proliferation change of human glioblastoma U87MG cells exposed to different concentrations (2.5-20.0 microg/ml) of asterosaponin 1 for a certain time. The results showed that asterosaponin 1 significantly suppressed U87MG cell proliferation in a time- and dose-dependent manner (IC50 =4.3 microg/ml). Flow cytometric analysis of DNA in U87MG cells showed that asterosaponin 1 induces the prominent appearance of a sub-G1 peak in the cell cycle suggestive of apoptosis identical with the result of annexin V/PI assay. Furthermore, U87MG cells treatment with asterosaponin 1 resulted in nuclear condensation with apoptotic bodies observed by both fluorescence and electron microscopy. Agarose gel electrophoresis of DNA from asterosaponin 1-treated cells revealed a typical "ladder" consistent with apoptotic DNA fragmentation. Western-blot staining showed asterosaponin 1 decreased the expression of Bcl-2 protein and increased the expression of Bax protein. The novel findings suggest that the cytostatic actions of asterosaponin 1 toward U87MG cells result from the induction of cell apoptosis. Overall, our data demonstrate that asterosaponin 1 is fully equipped for an efficient apoptotic killing of glioblastoma cells and suggest that this mechanism may play a critical role in anti-tumor chemotherapy.
Bernardi,
Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane.
1994, Pubmed
Bernardi,
Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane.
1994,
Pubmed
Boudreau,
Gliomas: advances in molecular analysis and characterization.
2005,
Pubmed
Curtin,
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.
2005,
Pubmed
De Marino,
Starfish saponins. 55. Isolation, structure elucidation, and biological activity of the steroid oligoglycosides from an Antarctic starfish of the family Asteriidae.
1998,
Pubmed
,
Echinobase
Filomeni,
Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide.
2003,
Pubmed
Gautam,
Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane).
1998,
Pubmed
Geske,
The biology of apoptosis.
2001,
Pubmed
Gliński,
Altered therapy schedules in postoperative treatment of patients with malignant gliomas. Twenty year experience of the Maria Skłodowska-Curie Memorial Center in Kraków, 1973-1993.
1998,
Pubmed
Ha,
Methylene chloride fraction of Spatholobi Caulis induces apoptosis via caspase dependent pathway in U937 cells.
2004,
Pubmed
Handrick,
Bcl-2 mediated inhibition of erucylphosphocholine-induced apoptosis depends on its subcellular localisation.
2005,
Pubmed
Hao,
PC-407 inhibited proliferation and induced apoptosis in human colon cancer SW-1116 cells.
2004,
Pubmed
Hegi,
MGMT gene silencing and benefit from temozolomide in glioblastoma.
2005,
Pubmed
Hockenbery,
bcl-2 in cancer, development and apoptosis.
1994,
Pubmed
Kuo,
Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells.
1996,
Pubmed
Leist,
Four deaths and a funeral: from caspases to alternative mechanisms.
2001,
Pubmed
Lövborg,
Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828.
2004,
Pubmed
Malerba,
Induction of apoptosis and inhibition of telomerase activity in human bone marrow and HL-60 p53 null cells treated with anti-cancer drugs.
2005,
Pubmed
Mickisch,
Chemosensitivity testing of primary human renal cell carcinoma by a tetrazolium based microculture assay (MTT).
1990,
Pubmed
Nakagawa,
Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines.
2001,
Pubmed
Obrero,
Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death.
2002,
Pubmed
Reed,
Postmitochondrial regulation of apoptosis during heart failure.
1999,
Pubmed
Scaife,
G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium.
2004,
Pubmed
Shackelford,
Cell cycle control, checkpoint mechanisms, and genotoxic stress.
1999,
Pubmed
Snider,
Apoptosis and necrosis in cerebrovascular disease.
1999,
Pubmed
Tang,
Bioactive asterosaponins from the starfish Culcita novaeguineae.
2005,
Pubmed
,
Echinobase
Tang,
Three new asterosaponins from the starfish Culcita novaeguineae and their bioactivity.
2005,
Pubmed
,
Echinobase
Tang,
Asterosaponins from the starfish Culcita novaeguineae and their bioactivities.
2006,
Pubmed
,
Echinobase
Tsujimoto,
Cell death regulation by the Bcl-2 protein family in the mitochondria.
2003,
Pubmed
Vindeløv,
An integrated set of methods for routine flow cytometric DNA analysis.
1990,
Pubmed
van Engeland,
A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture.
1996,
Pubmed
